Abstract
Background Orofacial cancer is a malignant neoplastic proliferation of epithelial and ectomesenchymal tissue of oral and maxillofacial origin. The late presentation of patient, aggressive nature of orofacial malignancy and the anatomic site closure to vital organ make orofacial cancer management challenging.
Objective The goal of this was to assess the patterns and risk factors of primary orofacial malignancy among patients visited Tikur Anbessa comprehensive specialized hospital.
Patients and methods A cross sectional descriptive study with retrospective data collection was conducted on 175 patients diagnosed with primary oral and maxillofacial malignancies at Tikur Anbessa comprehensive specialized hospital over a period of January 2020 to December 2021. Data were collected by chart review. The collected date were entered to SPSS 25.0 for statistical analysis and results were presented with table, figures and charts. Percentage and frequency were employed for categorical data while mean was used for continuous variables.
Results Out of 175 primary orofacial cases analysed, male were 57.1 %(n=100) with male to female ratio 1.48: 1, mean age of (48.21 ± 16.93 years) and range (12–91 years). Squamous cell carcinoma was the commonest cancer (52.0%) followed by mucoepidermoid carcinoma. About 34 % of patient had known risk factor. Majority of the patient (65.7%) were diagnosed as stage IV. Distance metastases were identified in 8.6 % of the patients and 41.7% of patients were treated surgically.
Conclusion The study showed squamous cell carcinoma was the most prevalent orofacial cancer. Majority of patients were presented with advanced stage of disease. Surgery was the main means of treatment modality given to orofacial cancer patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Permission of ethical issue and ethical clearance was obtained from research and ethics committee of department of Dentistry, College health science, AAU before the study. This research was conducted in full accordance with the World Medical Association Declaration of Helsinki. We confirmed that patients' information remained confidential and data was anonymized and de‐identified to analysis. Patient name was not recorded and patient information kept confidential.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files
